The Impact of Standard High-Flux Polysulfone Versus Novel High-Flux Polysulfone Dialysis Membranes on Inflammatory Markers: A Randomized, Single-Blinded, Controlled Clinical Trial

Peter Kerr, Wayne H F Sutherland, Slyvia De Jong, Indran Vaithalingham, Sheila M Williams, Robert J Walker

Research output: Contribution to journalArticleResearchpeer-review

18 Citations (Scopus)

Abstract

Background: This study is a prospective, randomized, single-blind, clinical trial over 12 months involving 60 stable hemodialysis patients comparing standard high-flux polysulfone dialyzer membranes with a novel high-flux polysulfone dialyzer membrane (Helixone; Fresenius Medical Care, St Wendel, Germany) modified in the fiber-spinning process to enhance middle-molecule clearance through changing the distribution of pore size and increased filtration.
Original languageEnglish
Pages (from-to)533 - 539
Number of pages7
JournalAmerican Journal of Kidney Diseases
Volume49
Issue number4
DOIs
Publication statusPublished - 2007

Cite this